CA
PTX

Cliff Asness’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Cliff Asness’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-143,960
Closed -$645K – 2334
2016
Q2 		$645K Buy
143,960
+42,649
+42% +$278K ﹤0.01% 1779
2016
Q1 		$1.06M Buy
101,311
+10,091
+11% +$201K ﹤0.01% 1556
2015
Q4 		$2.69M Buy
91,220
+47,973
+111% +$1.45M ﹤0.01% 1117
2015
Q3 		$1.37M Buy
43,247
+21,468
+99% +$1.03M ﹤0.01% 1288
2015
Q2 		$1.29M Buy
21,779
+10,193
+88% +$719K ﹤0.01% 1381
2015
Q1 		$1.24M Sell
11,586
-14,920
-56% -$1.42M ﹤0.01% 1321
2014
Q4 		$2.49M Sell
26,506
-534
-2% -$50.9K 0.01% 1188
2014
Q3 		$2.08M Buy
27,040
+24,570
+995% +$1.93M 0.01% 1245
2014
Q2 		$222K Buy
+2,470
New +$151K ﹤0.01% 2330

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Cliff Asness's PTX Position: Q3 2016 in Review

Cliff Asness sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 143,960 shares — an estimated $645K sold.

Cliff Asness first reported a position in PTX in Q2 2014 and held it in 9 quarters. The position peaked at $2.69M in Q4 2015. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

  • Cliff Asness reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Cliff Asness sold 143,960 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $645K.
  • Cliff Asness first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 9 quarters.
  • Cliff Asness's Pernix Therapeutics Holdings, Inc. position peaked at $2.69M in Q4 2015.
  • 48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on AQR Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.